Company intelligence / Profile preview

Beacon Pharmaceuticals

Dhaka, Dhaka, Bangladeshbeaconpharma.com.bd ↗
Ownership
Private
Employees
~2571
Development stage
Other
01

Overview

Beacon Pharmaceuticals is the leading oncology and generic drug manufacturer in Bangladesh, with more than 200 generic medicines and 65+ oncology drugs marketed and exported. The company also introduces 15–20 new high-tech products annually, and is known for launching global first generics (the first generic version available worldwide for some molecules), such as generic osimertinib, brigatinib, and more.

Therapeutic areas
EndocrinologyInfectious DiseasesHematologyCardiovascularOncologyNeurology
Modalities
Small moleculeMonoclonal antibodyBiologicNanoparticle
Industry
Biotech
02

Drug pipeline

1 asset

Xitabin

Unknown

Beyond the preview

Go deeper on Beacon Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacon Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call